Biomedical subjects
M D Schnall
Publications and source records attributed to M D Schnall.
Multicoil array for high resolution imaging of the breast.
An RF multicoil array for high resolution imaging of the breast is presented. The RF multicoil is incorporated into a dedicated breast imaging apparatus that holds either breast in gentle compression during imaging. Simulations and imaging experiments demonstrate the high sensitivity and RF homogeneity of the multicoil array. Direct comparisons are made between the multicoil and a surface coil. In vivo images are presented to demonstrate the homogeneity of the RF field of the multicoil over the entire breast. An in vivo image of both high temporal and spatial resolution is shown, which demonstrates the sensitivity of the RF multicoil array that may be achieved in a practical imaging experiment.
Magnetic resonance angiography of the aortic arch.
Duplex ultrasound and magnetic resonance angiographic (MRA) studies are the principal noninvasive methods for evaluation of extracranial occlusive disease in patients at risk for stroke, but each has limited ability to diagnose aortic arch and arch vessel disease. Recent favorable reports of the nonnephrotoxic contrast agent Gadolinium (Gd) being used to enhance MRA images of the abdominal aorta prompted us to examine its utility for the aortic arch vessels. Prospectively, 28 patients with suspected carotid or arch vessel disease were imaged by contrast arteriographic examination and MRA + Gd of the aortic arch within 30 days of each other. One (for contrast arteriograms) or two (for MRA) blinded readers measured stenoses with the contrast arteriograms as the standard. A total of 196 arch vessels containing 58 stenoses and four occlusions (by arteriogram) were examined with each method. Interobserver agreement for interpretation of MRA studies was substantial (kappa = 0.68). MRA detected all anatomic anomalies (e.g., bovine arch). The correlation of MRA with arteriographic scans for arch vessel stenoses > 50% was sensitivity, 73% (readers 1 and 2); specificity, 98% (reader 1), 89% (reader 2); positive predictive value, 73% (reader 1), 89% (reader 2); negative predictive value, 98% (readers 1 and 2); accuracy, 97% (reader 1), 98% (reader 2). MRA + Gd is an accurate new noninvasive imaging method for detection of significant aortic arch disease. In its current state of development, however, it cannot obviate the need for contrast arteriographic examination.
Primary hepatic angiocentric lymphoma.
Explore the source record for details and available documents.
Staging prostate cancer with MR imaging: a combined radiologist-computer system.
PURPOSE: To test the accuracy of a combined radiologist-computer system in the diagnosis with magnetic resonance (MR) imaging of cancer of the prostate gland. MATERIALS AND METHODS: The combined system was developed and tested by four specialists in prostate MR imaging and five radiologists expert in body MR imaging. Each group read MR images obtained in 100 proved cases of prostate cancer. The images were obtained from two sources, and all were obtained with an endorectal surface coil. Prostate MR specialists ranked imaging features of cases to develop a checklist for image interpretation. Features with greatest diagnostic value were incorporated in the combined system. Accuracy measures were derived from the area index of the receiver operating characteristic curve for the combined system and compared with those of radiologists working alone. RESULTS: Body MR radiologists had a mean baseline accuracy of 0.67; mean accuracy of their combined system was 0.80. The prostate MR specialists, when they rated the features in each case, had a mean accuracy of 0.81; the accuracy of their combined system was 0.87. CONCLUSIONS: A combined radiologist-computer system substantially improved accuracy of body MR radiologists in the diagnosis of prostate cancer. High levels of accuracy were also achieved by the system with prostate MR specialists.
MR imaging of ductal carcinoma in situ.
PURPOSE: To investigate the ability of magnetic resonance (MR) imaging to depict ductal carcinoma in situ (DCIS). MATERIALS AND METHODS: Between January 1992 and April 1996, 330 women underwent MR imaging before excisional biopsy. Of these, 101 women had carcinoma, 19 of whom had DCIS. The MR imaging findings in the 19 women were reviewed. RESULTS: Thirteen of 19 patients had pure DCIS. The mean lesion diameter was 10 mm (range, 2-22 mm). MR imaging enabled identification of DCIS in 10 (77%) of the 13 cases as ductal enhancement (n = 6), regional enhancement (n = 3), or a peripherally enhancing mass (n = 1). The three lesions not identified had a mean diameter of 3.7 mm. Six of 19 patients had both DCIS and an invasive cancer. In four of these patients, DCIS was identified only at MR imaging (mean diameter, 3 mm). In two of six patients, DCIS was not identified at MR imaging. CONCLUSION: MR imaging can depict mammographically visible and occult foci of DCIS. Some small foci of DCIS detected at mammography and histologic examination, however, may be occult at MR imaging.
Breast MR imaging: interpretation model.
PURPOSE: To develop an interpretation model based on architectural features of suspicious breast findings on magnetic resonance (MR) images. MATERIALS AND METHODS: One hundred ninety-two patients with mammographically visible or palpable findings underwent T1- and fat-saturated T2-weighted spin-echo and contrast agent-enhanced fat-saturated gradient-echo MR imaging. Patients underwent subsequent excisional biopsy for histopathologic confirmation. An interpretation model was constructed by using 98 cases and was tested prospectively and expanded by using 94 different cases. Sensitivity, specificity, predictive values, and receiver operating characteristic curves were computed for all models. RESULTS: Individual features with high predictive values were MR visibility, enhancement degree and pattern, focal mass border characteristics, and focal mass internal septations. Feature combinations with high negative predictive values for malignancy were absence of an MR-visible abnormality, focal masses with smooth borders, lobulated or irregular masses with nonenhancing internal septations, and focal masses with no (or minimal) enhancement. The validated- and revised-model performance characteristics were, respectively, as follows: sensitivity, 100% and 96%; specificity, 69% and 79%; positive predictive value, 75% and 76%; negative predictive value, 100% and 97%; and overall accuracy, 83% and 86%. CONCLUSION: An interpretation model that incorporates breast MR architectural features can achieve high sensitivity and improve specificity for diagnosing breast cancer.
Fibroadenomas: MR imaging appearances with radiologic-histopathologic correlation.
PURPOSE: To identify histopathologic correlates for the varied magnetic resonance (MR) imaging appearances of fibroadenomas. MATERIALS AND METHODS: Twenty-three fibroadenomas in 21 patients (aged 23-66 years) examined with gadolinium-enhanced MR imaging were graded for signal intensity on T2-weighted images, contrast material enhancement, shape, and internal septations and were correlated with histopathologic findings. RESULTS: Fibroadenomas demonstrated high T2 signal intensity with enhancement (n = 11), low T2 signal intensity with enhancement (n = 3), or low T2 signal intensity without enhancement (n = 9). Low T2 signal intensity and lack of enhancement were associated with more sclerotic stroma and older patient age. Lesion shape was lobular, oval, or round in 19 of 23 fibroadenomas (83%). Internal septations were identified within nine of 14 enhancing fibroadenomas (64%) and appeared to correlate with collagenous bands at histopathologic analysis. CONCLUSION: Fibroadenomas demonstrate marked histopathologic variability. The resultant variability in the MR appearance limits the ability to distinguish between benign and malignant masses on the basis of signal intensity and enhancement alone. Lobulation and internal septation, which appear to reflect intrinsic growth patterns of fibroadenomas, may provide a more reliable basis for distinction.
Breast carcinoma: MR imaging before re-excisional biopsy.
PURPOSE: To investigate the role of magnetic resonance (MR) imaging in the examination of patients after excisional biopsy of breast carcinoma before re-excision. MATERIALS AND METHODS: Forty-seven patients underwent contrast material-enhanced MR imaging after initial excisional biopsy of breast carcinoma before further surgery. RESULTS: The positive predictive value of MR imaging for predicting residual disease was 82%; the negative predictive value was 61%. Fourteen patients had multifocal (n = 6) or diffuse (n = 8) carcinoma. The extent of tumor was correctly identified with MR imaging alone in nine of the 14 patients, with both mammography and MR imaging in three patients, with mammography alone in one patient, and with no imaging modality in one patient. In four of the 14 patients, management was altered from re-excision to mastectomy (n = 3) or from breast-conservation therapy to mastectomy (n = 1). CONCLUSION: MR imaging has a high positive predictive value for predicting residual tumor after excisional biopsy. The identification of mammographically and clinically unsuspected multifocal or extensive residual tumor may lend support for mastectomy rather than re-excision. However, false-negative findings due to postsurgical changes and false-positive findings due to enhancement of granulation tissue and benign breast tissue remain limitations.
Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the renovascular system.
Explore the source record for details and available documents.
Diagnostic performance characteristics of architectural features revealed by high spatial-resolution MR imaging of the breast.
OBJECTIVE: Our objective was twofold: to determine which architectural features revealed by high spatial-resolution MR imaging of the breast contribute to diagnostic accuracy and to evaluate the diagnostic performance characteristics of those architectural features. MATERIALS AND METHODS: Eligible patients with suspicious mammographic or palpable findings or both underwent MR imaging. Ninety-three patients whose MR images revealed lesions that corresponded to the mammographically visible or palpable findings were included in the study. Patients were examined with sagittal T1-weighted spin-echo MR imaging, fat-saturated T2-weighted fast spin-echo MR imaging, and dynamically enhanced fat-saturated fast gradient-echo MR imaging. All patients underwent subsequent excisional biopsy or cyst aspiration. Lesions were identified initially by an experienced radiologist who was aware of the patient's clinical or mammographic information. Two radiologists who were unaware of the patients' histories and who had less experience in MR imaging of the breast then independently evaluated each lesion for the architectural-features and predicted each lesion's potential for malignancy. RESULTS: Architectural features that were highly predictive of benign disease included smooth or lobulated borders (97-100%), the absence of mass enhancement (100%), and enhancement that was less than the enhancement of surrounding breast fibroglandular tissue (93-100%). Nonenhancing internal septations were specific for the diagnosis of fibroadenoma. Architectural features that were highly predictive of malignant disease included spiculated borders (76-88%) and peripheral rim enhancement in the presence of central lesion enhancement (79-92%). CONCLUSION: Architectural features revealed by high spatial-resolution MR imaging of the breast can help distinguish benign from malignant disease.
Bilateral angiosarcoma of the breast on MR imaging.
Explore the source record for details and available documents.
Signal characteristics of tumors shown by high-resolution endorectal coil magnetic resonance imaging may predict outcome among patients with cervical carcinoma treated with irradiation. A preliminary study.
BACKGROUND: The purpose of this study was to evaluate the role of high-resolution magnetic resonance imaging with the endorectal coil (eMRI) in the management of cervical carcinoma treated with definitive irradiation. METHODS: Eighteen patients with invasive cervical carcinoma (International Federation of Gynecology and Obstetrics Stages Ib-IIIb) consented to evaluation with eMRI on a 1.5 tesla system with high resolution (400 x 400 microM). Images were read to provide staging information and to grade the signal characteristics of the individual tumors as low (dark), intermediate, or high (bright) relative to surrounding isointense fat. Patients were treated with standard megavoltage irradiation (prescribed dose, 80-85 Gray); shaped antero-posterior/postero-anterior or 4-field box techniques, plus brachytherapy, were used. RESULTS: In 39% of patients, tumors were determined to be in a higher stage by eMRI because of proximal vaginal involvement (n = 4) or the combination of proximal vaginal involvement and parametrial extension (n = 3). Features predictive of improved local control and survival without evidence of disease included stage, hemoglobin levels > or = 11, complete response to external irradiation, and bright signal characteristics. Compared with those who had dark and/or intermediate tumors, patients who had tumors with bright signal characteristics tended to present with earlier stage disease, were less likely to have anemia, and were more likely to have complete response to external irradiation. CONCLUSIONS: Prognostic information for clinical staging of cervical carcinoma was contributed by eMRI. The technique was more likely to suggest proximal vaginal involvement by a tumor than was examination under anesthesia. Signal characteristics of tumors may provide valuable predictive information that is supplementary to conventional discriminants of outcome that follow definitive irradiation. Such information could allow physicians to tailor treatment (e.g., by the addition of radiation sensitizers) at an earlier point in disease management.
Magnetic resonance imaging of the uterine body, cervix, and adnexa.
Explore the source record for details and available documents.
Cost-effectiveness of endorectal magnetic resonance imaging for the staging of prostate cancer.
Explore the source record for details and available documents.
High-resolution MR imaging of the breast: clinical context.
Preliminary investigation into magnetic resonance (MR) imaging as a breast imaging technique has demonstrated several promising roles for this modality when used as an adjunct to mammography for the detection and diagnosis of breast cancer. There are many technical factors that must be considered, including high resolution, rapid imaging, fat suppression, and localization and biopsy capability. Potential clinical applications include differentiating benign from malignant lesions, detecting cancer when results of clinical examination or conventional imaging are equivocal, detecting cancer recurrence after breast conservation treatment, staging newly diagnosed breast cancer, and detecting occult cancer in patients presenting with axillary node metastasis. Pitfalls include false-positive and false-negative results. Awareness of the strengths and limitations of MR imaging of the breast will facilitate integration of this technique into the work-up of patients with suspicious breast lesions.
Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries.
OBJECTIVES: The objectives of this study were to develop and show the efficacy of a breath-hold ultrafast three-dimensional (3D) spoiled gradient-echo (SPGR) gadolinium-enhanced MR angiographic technique for imaging the aorta and the renal and other visceral arteries of the abdomen; and to compare breath-hold ultrafast 3D SPGR with two-dimensional (2D) time-of-flight (TOF) and non-breath-hold ultrafast 3D SPGR in the same patients. SUBJECTS AND METHODS: We prospectively studied the abdominal aorta and the renal and other visceral arteries 68 times in 63 consecutive patients with 2D TOF and ultrafast 3D SPGR MR angiography. Thirty-two patients had contrast angiography (n = 23) and/or surgery (n = 24) to serve as a gold standard. All MR imaging studies were performed on a 1.5-T scanner (General Electric Medical Systems, Milwaukee, WI) using an enhanced gradient system with maximum gradient strength of 2.3 gauss/cm reached in 150 microseconds. Axial 2D TOF parameters were: TR/TE, 33/5.5 msec; flip angle, 45 degrees; slice thickness, 2 mm; and no presaturation pulses. Coronal ultrafast 3D SPGR was performed before and after the i.v. administration of 40-60 cc of gadolinium. For the coronal ultrafast 3D SPGR, our parameters were: TR/TE, 4.8-7/1.1; flip angle, 60 degrees; 28-50 slices of 2.0-2.6 mm thickness; and acquisition time, 18-32 sec. Studies were read by a single radiologist [corrected] and were evaluated for the degree of stenosis in the renal, celiac, superior mesenteric, and inferior mesenteric arteries; any vascular anomalies (i.e., retroaortic renal veins and accessory renal or variant hepatic arteries) were noted. RESULTS: Breath-hold ultrafast 3D SPGR correctly identified 31 of 31 stenoses of the renal artery for a sensitivity, specificity, and accuracy of 100%. Two-dimensional TOF detected 23 of 31 renal artery stenoses for a sensitivity, specificity, and accuracy of 74%, 98%, and 87% respectively. Breath-hold ultrafast 3D SPGR underestimated two renal arteries as having severe osteal stenoses that were graded correctly by 2D TOF and by angiography as occlusions. Eight of nine (89%) accessory renal arteries were correctly identified with breath-hold ultrafast 3D SPGR: Two-dimensional TOF identified six of nine (67%). Breath-hold ultrafast 3D SPGR identified one accessory and two reconstituted renal arteries missed by 2D TOF and conventional contrast angiography that were confirmed at surgery. Ultrafast 3D SPGR and 2D TOF correctly identified 20 of 20 celiac, superior mesenteric, and inferior mesenteric artery osteal stenoses or occlusions for a sensitivity, specificity, and accuracy of 100%. Three Riolan's arcs were correctly identified by breath-hold 3D SPGR but were missed by 2D TOF: Forty of the 63 patients did not have conventional contrast angiography and were managed surgically (n = 9) or medically (n = 31) based on the results of the MR angiograms and clinical data. Breath-hold ultrafast 3D SPGR MR angiography correctly identified and graded 48 of 51 renal, celiac, superior mesenteric, and inferior mesenteric artery stenoses or occlusions. Two-dimensional TOF MR angiography correctly identified and graded 45 of 51 renal, celiac, superior mesenteric, and inferior mesenteric artery stenoses and occlusions. CONCLUSION: Breath-hold ultrafast 3D SPGR when combined with 2D TOF accurately identified and graded all (51 of 51) renal, celiac, superior mesenteric, and inferior mesenteric artery stenoses or occlusions.
Contrast-enhanced MR imaging of the bladder and prostate.
The staging of both bladder and prostate carcinoma is important to determine appropriate therapy. Routine clinical staging of these tumors, however, has only limited accuracy. This article reviews the literature on contrast-enhanced MR of both bladder and prostate cancer, including technique optimization and potential benefits of contrast-enhanced studies.